advertisement
Abstract #104692 Published in IGR 23-2
Treatment of Massive Suprachoroidal Hemorrhage by Drainage Surgery with Vitrectomy: Experience of a Single Center
Chen X; Hou B; Yin L; Wang FSeminars in Ophthalmology 2022; 37: 767-773
PURPOSE: The present study assessed the treatment of and risk factors for suprachoroidal hemorrhage (SCH) and reported the outcomes of drainage surgery with vitrectomy in a consecutive series of patients. METHODS: Retrospective case series were carried out to investigate the clinical data of 12 eyes from 12 patients who underwent suprachoroidal hemorrhage drainage with vitrectomy surgery over a 10-year period (from 2010 to 2020). The records of these patients were analyzed, including ophthalmologic examination, ophthalmologic ultrasonography, surgical procedures, and outcome measurements. RESULTS: Twelve consecutive patients with a mean age of 56.5 years were studied. Intraocular surgery, high myopia, glaucoma, hypertension and anticoagulant therapy were the most common risk factors for SCH. All patients underwent external drainage and pars plana vitrectomy surgery. All of the patients were followed up for 10.2 months. Overall, the mean preoperative BCVA improved from 2.3 LogMAR to 1.7 LogMAR at the last follow-up visit ( = .041). CONCLUSIONS: The risk factors for SCH include high myopia, glaucoma, hypertension and anticoagulant therapy. Drainage of SCH with vitrectomy is a valuable approach in the management of SCH.
Department of Ophthalmology, The Chinese PLA General Hospital, Beijing, China.
Full article